Logo image of PHI

PLDT INC-SPON ADR (PHI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PHI - US69344D4088 - ADR

21.94 USD
-0.01 (-0.05%)
Last: 12/16/2025, 2:27:50 PM
Fundamental Rating

4

Taking everything into account, PHI scores 4 out of 10 in our fundamental rating. PHI was compared to 22 industry peers in the Wireless Telecommunication Services industry. While PHI has a great profitability rating, there are quite some concerns on its financial health. PHI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PHI was profitable.
In the past year PHI had a positive cash flow from operations.
In the past 5 years PHI has always been profitable.
In the past 5 years PHI always reported a positive cash flow from operatings.
PHI Yearly Net Income VS EBIT VS OCF VS FCFPHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

With a decent Return On Assets value of 4.65%, PHI is doing good in the industry, outperforming 63.64% of the companies in the same industry.
The Return On Equity of PHI (24.31%) is better than 81.82% of its industry peers.
The Return On Invested Capital of PHI (8.37%) is better than 72.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PHI is in line with the industry average of 6.45%.
The last Return On Invested Capital (8.37%) for PHI is above the 3 year average (5.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.65%
ROE 24.31%
ROIC 8.37%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
PHI Yearly ROA, ROE, ROICPHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

PHI has a better Profit Margin (13.35%) than 77.27% of its industry peers.
In the last couple of years the Profit Margin of PHI has grown nicely.
PHI has a Operating Margin of 23.74%. This is amongst the best in the industry. PHI outperforms 90.91% of its industry peers.
In the last couple of years the Operating Margin of PHI has remained more or less at the same level.
With an excellent Gross Margin value of 86.54%, PHI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Gross Margin of PHI has remained more or less at the same level.
Industry RankSector Rank
OM 23.74%
PM (TTM) 13.35%
GM 86.54%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
PHI Yearly Profit, Operating, Gross MarginsPHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHI is creating value.
PHI has about the same amout of shares outstanding than it did 1 year ago.
PHI has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for PHI is higher compared to a year ago.
PHI Yearly Shares OutstandingPHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
PHI Yearly Total Debt VS Total AssetsPHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that PHI is in the distress zone and has some risk of bankruptcy.
PHI's Altman-Z score of 0.84 is on the low side compared to the rest of the industry. PHI is outperformed by 63.64% of its industry peers.
PHI has a debt to FCF ratio of 20.27. This is a negative value and a sign of low solvency as PHI would need 20.27 years to pay back of all of its debts.
The Debt to FCF ratio of PHI (20.27) is worse than 63.64% of its industry peers.
A Debt/Equity ratio of 2.76 is on the high side and indicates that PHI has dependencies on debt financing.
The Debt to Equity ratio of PHI (2.76) is worse than 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.76
Debt/FCF 20.27
Altman-Z 0.84
ROIC/WACC3.08
WACC2.72%
PHI Yearly LT Debt VS Equity VS FCFPHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

A Current Ratio of 0.38 indicates that PHI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.38, PHI is doing worse than 90.91% of the companies in the same industry.
PHI has a Quick Ratio of 0.38. This is a bad value and indicates that PHI is not financially healthy enough and could expect problems in meeting its short term obligations.
PHI has a worse Quick ratio (0.37) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.37
PHI Yearly Current Assets VS Current LiabilitesPHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

3

3. Growth

3.1 Past

The earnings per share for PHI have decreased by -2.37% in the last year.
PHI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.18% yearly.
Looking at the last year, PHI shows a small growth in Revenue. The Revenue has grown by 1.69% in the last year.
PHI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.09% yearly.
EPS 1Y (TTM)-2.37%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%-10.71%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%0.66%

3.2 Future

The Earnings Per Share is expected to grow by 2.22% on average over the next years.
Based on estimates for the next years, PHI will show a small growth in Revenue. The Revenue will grow by 2.17% on average per year.
EPS Next Y-0.88%
EPS Next 2Y1.39%
EPS Next 3Y2.22%
EPS Next 5YN/A
Revenue Next Year1.37%
Revenue Next 2Y2%
Revenue Next 3Y2.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PHI Yearly Revenue VS EstimatesPHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50B 100B 150B 200B
PHI Yearly EPS VS EstimatesPHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.25, the valuation of PHI can be described as very reasonable.
PHI's Price/Earnings ratio is rather cheap when compared to the industry. PHI is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of PHI to the average of the S&P500 Index (26.55), we can say PHI is valued rather cheaply.
The Price/Forward Earnings ratio is 7.78, which indicates a rather cheap valuation of PHI.
Based on the Price/Forward Earnings ratio, PHI is valued cheaper than 90.91% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.78. PHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.25
Fwd PE 7.78
PHI Price Earnings VS Forward Price EarningsPHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHI is valued a bit cheaper than 72.73% of the companies in the same industry.
PHI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 15.81
EV/EBITDA 5.56
PHI Per share dataPHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PHI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.59
EPS Next 2Y1.39%
EPS Next 3Y2.22%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.54%, PHI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.55, PHI pays a bit more dividend than its industry peers.
PHI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 7.54%

5.2 History

The dividend of PHI has a limited annual growth rate of 5.62%.
PHI has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)5.62%
Div Incr Years0
Div Non Decr Years0
PHI Yearly Dividends per sharePHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

70.37% of the earnings are spent on dividend by PHI. This is not a sustainable payout ratio.
PHI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP70.37%
EPS Next 2Y1.39%
EPS Next 3Y2.22%
PHI Yearly Income VS Free CF VS DividendPHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B
PHI Dividend Payout.PHI Dividend Payout, showing the Payout Ratio.PHI Dividend Payout.PayoutRetained Earnings

PLDT INC-SPON ADR

NYSE:PHI (12/16/2025, 2:27:50 PM)

21.94

-0.01 (-0.05%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners5.15%
Inst Owner Change-5.66%
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap4.74B
Revenue(TTM)219.17B
Net Income(TTM)29.25B
Analysts82.5
Price Target28.5 (29.9%)
Short Float %0.47%
Short Ratio4.58
Dividend
Industry RankSector Rank
Dividend Yield 7.54%
Yearly Dividend1.63
Dividend Growth(5Y)5.62%
DP70.37%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-27 2025-08-27 (0.842656)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.38%
Min EPS beat(2)-9.26%
Max EPS beat(2)-3.5%
EPS beat(4)1
Avg EPS beat(4)-1.99%
Min EPS beat(4)-9.26%
Max EPS beat(4)5.39%
EPS beat(8)3
Avg EPS beat(8)1.52%
EPS beat(12)7
Avg EPS beat(12)10.07%
EPS beat(16)11
Avg EPS beat(16)11.63%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.44%
PT rev (3m)-3.32%
EPS NQ rev (1m)-2.83%
EPS NQ rev (3m)-2.83%
EPS NY rev (1m)-0.55%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 8.25
Fwd PE 7.78
P/S 1.28
P/FCF 15.81
P/OCF 3.13
P/B 2.32
P/tB 4.99
EV/EBITDA 5.56
EPS(TTM)2.66
EY12.12%
EPS(NY)2.82
Fwd EY12.86%
FCF(TTM)1.39
FCFY6.32%
OCF(TTM)7.02
OCFY31.98%
SpS17.2
BVpS9.45
TBVpS4.39
PEG (NY)N/A
PEG (5Y)1.59
Graham Number23.78
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 24.31%
ROCE 11.16%
ROIC 8.37%
ROICexc 8.56%
ROICexgc 9.96%
OM 23.74%
PM (TTM) 13.35%
GM 86.54%
FCFM 8.06%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
ROICexc(3y)6.02%
ROICexc(5y)7.44%
ROICexgc(3y)7.16%
ROICexgc(5y)9.04%
ROCE(3y)7.76%
ROCE(5y)9.05%
ROICexgc growth 3Y-2.13%
ROICexgc growth 5Y-4.68%
ROICexc growth 3Y-0.98%
ROICexc growth 5Y-2.62%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 2.76
Debt/FCF 20.27
Debt/EBITDA 2.95
Cap/Depr 118.1%
Cap/Sales 32.72%
Interest Coverage 4.04
Cash Conversion 79.27%
Profit Quality 60.43%
Current Ratio 0.38
Quick Ratio 0.37
Altman-Z 0.84
F-Score6
WACC2.72%
ROIC/WACC3.08
Cap/Depr(3y)117.23%
Cap/Depr(5y)139.41%
Cap/Sales(3y)38.48%
Cap/Sales(5y)42.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.37%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%-10.71%
EPS Next Y-0.88%
EPS Next 2Y1.39%
EPS Next 3Y2.22%
EPS Next 5YN/A
Revenue 1Y (TTM)1.69%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%0.66%
Revenue Next Year1.37%
Revenue Next 2Y2%
Revenue Next 3Y2.17%
Revenue Next 5YN/A
EBIT growth 1Y19.15%
EBIT growth 3Y6.08%
EBIT growth 5Y5.44%
EBIT Next Year99.31%
EBIT Next 3Y28.02%
EBIT Next 5YN/A
FCF growth 1Y213.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.66%
OCF growth 3Y-3.86%
OCF growth 5Y3.33%

PLDT INC-SPON ADR / PHI FAQ

Can you provide the ChartMill fundamental rating for PLDT INC-SPON ADR?

ChartMill assigns a fundamental rating of 4 / 10 to PHI.


Can you provide the valuation status for PLDT INC-SPON ADR?

ChartMill assigns a valuation rating of 6 / 10 to PLDT INC-SPON ADR (PHI). This can be considered as Fairly Valued.


How profitable is PLDT INC-SPON ADR (PHI) stock?

PLDT INC-SPON ADR (PHI) has a profitability rating of 8 / 10.


What is the financial health of PLDT INC-SPON ADR (PHI) stock?

The financial health rating of PLDT INC-SPON ADR (PHI) is 1 / 10.


What is the earnings growth outlook for PLDT INC-SPON ADR?

The Earnings per Share (EPS) of PLDT INC-SPON ADR (PHI) is expected to decline by -0.88% in the next year.